| Literature DB >> 27004526 |
David A Akinpelu1,2,3, Joseph O Odewade1, Olayinka A Aiyegoro4,5, Anofi O T Ashafa3, Oluseun F Akinpelu6, Mayowa O Agunbiade3.
Abstract
BACKGROUND: Staphylococcus aureus causes variety of infections in humans and animals worldwide and predominates in surgical wound infections. This study assessed the antimicrobial potential of the stem bark extract of Chrysophyllum albidum against an array of vancomycin resistant Staphylococcus aureus (VRSA) isolated from clinical samples.Entities:
Keywords: Chrysophyllum albidum; Clinical samples; Methanolic extract; Minimum bactericidal concentrations; Minimum inhibitory concentrations; Nucleotide; Phytochemicals; Potassium ion; Time kill; Vancomycin resistant Staphylococcus aureus
Mesh:
Substances:
Year: 2016 PMID: 27004526 PMCID: PMC4802705 DOI: 10.1186/s12906-016-1080-6
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Sensitivity patterns exhibited by fractions obtained from Chrysophyllum albidum against the bacterial isolates
| Zones of inhibition (mm)a | |||||||
|---|---|---|---|---|---|---|---|
| Bacterial isolates | BUT (10 mg/ml) | AQU (10 mg/ml) | n-HEX (10 mg/ml) | CHL (10 mg/ml) | ETHYL (10 mg/ml) | STREP (1 mg/ml) | AMP (1 mg/ml) |
| VRSA 1 | 11 ± 1.00 | 0 | 12.00 | 0 | 0 | 19 ± 1.41 | 0 |
| VRSA 2 | 13 ± 1.41 | 0 | 14 ± 0.71 | 0 | 0 | 14 ± 0.58 | 0 |
| VRSA 3 | 15 ± 0.71 | 0 | 13 ± 1.41 | 0 | 0 | 20 ± 0.71 | 17.00 |
| VRSA 4 | 14.00 | 0 | 13 ± 1.00 | 0 | 0 | 23 ± 1.00 | 18 ± 0.71 |
| VRSA 5 | 15 ± 0.58 | 0 | 12 ± 0.58 | 0 | 0 | 17 ± 1.20 | 16 ± 1.41 |
| VRSA 6 | 15 ± 1.41 | 0 | 13 ± 1.41 | 0 | 0 | 18 ± 1.41 | 18 ± 1.00 |
| VRSA 7 | 12.00 | 0 | 15 ± 1.00 | 0 | 0 | 20.00 | 20 ± 1.41 |
| VRSA 8 | 11 ± 0.56 | 0 | 10.00 | 0 | 0 | 18.00 | 0 |
| VRSA 9 | 11 ± 0.71 | 0 | 13 ± 0.56 | 0 | 0 | 16 ± 0.71 | 23 ± 0.56 |
| VRSA 10 | 13 ± 1.20 | 0 | 14 ± 0.71 | 0 | 0 | 0 | 18.00 |
| VRSA 11 | 11 ± 1.41 | 0 | 11 ± 0.54 | 0 | 0 | 0 | 16 ± 0.58 |
| VRSA 12 | 0 | 0 | 0 | 0 | 0 | 17.00 | 0 |
| VRSA 13 | 12 ± 1.00 | 0 | 14 ± 1.20 | 0 | 0 | 15.00 | 13 ± 0.71 |
| VRSA 14 | 10.00 | 0 | 11 ± 0.56 | 0 | 0 | 18.00 | 0 |
| VRSA 15 | 0 | 0 | 0 | 0 | 0 | 16 ± 0.58 | 0 |
| VRSA 16 | 11 ± 1.41 | 0 | 13 ± 1.00 | 0 | 0 | 19.00 | 22 ± 0.71 |
| VRSA 17 | 14.00 | 0 | 16.00 | 0 | 0 | 21 ± 0.56 | 13 ± 0.52 |
| VRSA 18 | 13 ± 0.52 | 0 | 15 ± 0.52 | 0 | 0 | 17.00 | 23.00 |
| VRSA 19 | 13 ± 1.00 | 0 | 12.00 | 0 | 0 | 19.00 | 0 |
| VRSA 20 | 13 ± 0.54 | 0 | 15 ± 0.54 | 0 | 0 | 0 | 18.00 |
| VRSA 21 | 13 ± 1.00 | 0 | 14.00 | 0 | 0 | 20 ± 1.00 | 15 ± 1.20 |
| VRSA 22 | 11 ± 0.71 | 0 | 13 ± 1.41 | 0 | 0 | 22.00 | 19 ± 0.54 |
| VRSA 23 | 13 ± 1.41 | 0 | 12.00 | 0 | 0 | 21 ± 0.54 | 17 ± 1.00 |
| VRSA 24 | 10.00 | 0 | 14 ± 0.71 | 0 | 0 | 23.00 | 20.00 |
| VRSA 25 | 11 ± 0.56 | 0 | 10.00 | 0 | 0 | 21.00 | 16 ± 1.41 |
| VRSA 26 | 12.00 | 0 | 16 ± 1.00 | 0 | 0 | 23 ± 1.20 | 0 |
| VRSA 27 | 15 ± 1.20 | 0 | 15 ± 1.20 | 0 | 0 | 22.00 | 19.00 |
| VRSA 28 | 13 ± 0.71 | 0 | 14.00 | 0 | 0 | 20.00 | 0 |
| VRSA 29 | 12 ± 0.58 | 0 | 12 ± 0.71 | 0 | 0 | 0 | 13 ± 0.54 |
| VRSA 30 | 14.00 | 0 | 15 ± 0.58 | 0 | 0 | 24.00 | 20.00 |
| VRSA 31 | 14 ± 0.71 | 0 | 11 ± 1.41 | 0 | 0 | 21.00 | 15.00 |
| VRSA 32 | 10.00 | 0 | 12 ± 1.00 | 0 | 0 | 19.00 | 16.00 |
| VRSA 33 | 13 ± 0.54 | 0 | 12.00 | 0 | 0 | 20.00 | 0 |
| VRSA 34 | 11 ± 1.00 | 0 | 12 ± 0.71 | 0 | 0 | 19 ± 0.71 | 20.00 |
| VRSA 35 | 16.00 | 0 | 15 ± 0.56 | 0 | 0 | 16.00 | 12.00 |
| VRSA 36 | 17 ± 0.71 | 0 | 16 ± 0.52 | 0 | 0 | 23 ± 0.58 | 21.00 ± 0.71 |
| VRSA 37 | 19 ± 1.20 | 0 | 18 ± 1.00 | 0 | 0 | 24 ± 0.70 | 22 ± 1.00 |
Key: BUT = Butanol fraction, AQU = Aqueous fraction, n-HEX = n-Hexane Fraction, CHL = Chloroform fraction, ETHYL = Ethy1 acetate fraction, STREP = Streptomycin and AMP = Ampicillin, a = Mean of three replicates, VRSA = Vancomycin resistant Staphylococcus aureus (Clinical strains), VRSA 36 = Staphylococcus aureus (NCIB 8588), VRSA 37 = Staphylococcus aureus (ATCC 6538)
The minimum inhibitory and bactericidal concentrations exhibited by the butanol and n-hexane fractions against susceptible bacterial isolates
| Butanol fraction | n-Hexane fraction | |||
|---|---|---|---|---|
| Bacterial isolates | MIC (mg/ml) | MBC (mg/ml) | MIC (mg/ml) | MBC (mg/ml) |
| VRSA 1 | 5.00 | 10.00 | 2.50 | 5.00 |
| VRSA 2 | ND | ND | 5.00 | 10.00 |
| VRSA 3 | 1.25 | 2.50 | 1.25 | 2.50 |
| VRSA 4 | 1.25 | 2.50 | 1.25 | 2.50 |
| VRSA 5 | 2.50 | 5.00 | 5.00 | 10.00 |
| VRSA 6 | 1.25 | 2.50 | 0.63 | 1.25 |
| VRSA 7 | 2.50 | 5.00 | 1.25 | 2.50 |
| VRSA 8 | ND | ND | 5.00 | 10.00 |
| VRSA 9 | 5.00 | 10.00 | ND | ND |
| VRSA 10 | 5.00 | 10.00 | 1.25 | 2.50 |
| VRSA 11 | 1.25 | 2.50 | 2.50 | 5.00 |
| VRSA 12 | ND | ND | ND | ND |
| VRSA 13 | ND | ND | ND | ND |
| VRSA 14 | 5.00 | 10.00 | ND | ND |
| VRSA 15 | ND | ND | ND | ND |
| VRSA 16 | 1.25 | 2.50 | 1.25 | 2.50 |
| VRSA 17 | 1.25 | 2.50 | 0.63 | 1.25 |
| VRSA 18 | ND | ND | 1.25 | 2.50 |
| VRSA 19 | 5.00 | 10.00 | ND | ND |
| VRSA 20 | 5.00 | 10.00 | 2.50 | 5.00 |
| VRSA 21 | 2.50 | 5.00 | ND | ND |
| VRSA 22 | ND | ND | ND | ND |
| VRSA 23 | 1.25 | 2.50 | 1.25 | 2.50 |
| VRSA 24 | 1.25 | 2.50 | 0.63 | 1.25 |
| VRSA 25 | 2.50 | 5.00 | 2.50 | 5.00 |
| VRSA 26 | 1.25 | 2.50 | 1.25 | 2.50 |
| VRSA 27 | 2.50 | 5.00 | 2.50 | 5.00 |
| VRSA 28 | 1.25 | 2.50 | 0.63 | 1.25 |
| VRSA 29 | 1.25 | 2.50 | 5.00 | 10.00 |
| VRSA 30 | 2.50 | 5.00 | 5.00 | 10.00 |
| VRSA 31 | 0.63 | 1.25 | 0.63 | 1.25 |
| VRSA 32 | 1.25 | 2.50 | 2.50 | 5.00 |
| VRSA 33 | 2.50 | 5.00 | 0.63 | 1.25 |
| VRSA 34 | 1.25 | 2.50 | 1.25 | 2.50 |
| VRSA 35 | ND | ND | ND | ND |
| VRSA 36 | 0.63 | 1.25 | 1.25 | 2.50 |
| VRSA 37 | 1.25 | 2.50 | 2.50 | 5.00 |
KEY: VRSA = Vancomycin resistant Staphylococcus aureus (Clinical strains), MIC = Minimum Inhibitory Concentration, MBC = Minimum Bactericidal Concentration, VRSA 36 = Staphylococcus aureus (NCIB 8588), VRSA 37 = Staphylococcus aureus (ATCC 6538), ND = Not Done
Preliminary phytochemical compounds obtained from the stem bark extract of Chrysophyllum albidum
| Chemical test | Result |
|---|---|
| Tannins | Positive |
| Alkaloids | Positive |
| Flavonoids | Positive |
| Saponins | Positive |
| Steroids | Positive |
| Reducing sugars | Positive |
| Terpenoids | Positive |
Fig. 1The extent and the rate of killing of test cells by n- hexane (a) and butanol (b) fractions at 1 × MIC (), 2 × MIC (), 3 × MIC () and control (). Each point represents the log10 of mean survival of bacterial cells at a particular time interval in the presence of the fraction
Fig. 2The effect of the n- hexane (a) and butanol (b) fractions on potassium ion leakage from test cells at 1 × MIC (), 2 × MIC (), 3 × MIC () and control (). Each point represents the amount of potassium ions leaked (μg/ml) from the cells at a particular time interval in the presence of the fraction
Fig. 3The effect of the n-hexane (a) and butanol (b) fractions on nucleotide leakage from test cells at 1 × MIC (), 2 × MIC (), 3 × MIC () and control (). Each point represents the quantity of nucleotides leaked (μg/ml) from the cells at a particular time interval in the presence of the fraction